Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03250832
What this trial is testing

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Tesaro, Inc. 111
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946836
What this trial is testing

Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study

Who this might be right for
Resectable Non-small Cell Lung CancerBispecific AntibodyNeoadjuvant Therapy
Shanghai Pulmonary Hospital, Shanghai, China 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469306
What this trial is testing

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fujian Cancer Hospital 130
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Testing effectiveness (Phase 2)UnknownNCT06509971
What this trial is testing

QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
West China Second University Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04080804
What this trial is testing

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Dan Zandberg 80
Early research (Phase 1)Study completedNCT02529072
What this trial is testing

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Who this might be right for
Malignant GliomaAstrocytomaGlioblastoma
Gary Archer Ph.D. 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05374512
What this trial is testing

Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

Who this might be right for
Breast Cancer
AstraZeneca 644
Testing effectiveness (Phase 2)Looking for participantsNCT06367075
What this trial is testing

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft-tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05994001
What this trial is testing

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Who this might be right for
Biliary Tract CancerCandonilimabClaudin 18.2
Shanghai Zhongshan Hospital 78
Testing effectiveness (Phase 2)Study completedNCT04895137
What this trial is testing

MFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC

Who this might be right for
Colorectal CancerImmunotherapy
Sixth Affiliated Hospital, Sun Yat-sen University 42
Not applicableStudy completedNCT03222440
What this trial is testing

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Large-scale testing (Phase 3)WithdrawnNCT03342352
What this trial is testing

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Who this might be right for
Head and Neck Cancer
Incyte Corporation
Testing effectiveness (Phase 2)UnknownNCT04815408
What this trial is testing

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

Who this might be right for
Ovarian CancerNeoadjuvant ChemotherapyAnti-PD-1+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Large-scale testing (Phase 3)Looking for participantsNCT05236972
What this trial is testing

PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Sun Yat-sen University 323
Early research (Phase 1)Study completedNCT04418401
What this trial is testing

Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 30
Testing effectiveness (Phase 2)Ended earlyNCT03645876
What this trial is testing

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560
What this trial is testing

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Lei Zheng 25
Testing effectiveness (Phase 2)Looking for participantsNCT07325539
What this trial is testing

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer
Sun Yat-sen University 55
Next Page